[A Case of Granulocyte Colony-Stimulating Factor-Related Aortitis that Developed during the Treatment of Advanced Prostate Cancer with Neuroendocrine Differentiation].
Tatsuya HazamaKohei MarunoToshifumi TakahashiYuya YamadaMasakazu NakashimaKazuro KikkawaMasahiro TamakiNoriyuki ItoPublished in: Hinyokika kiyo. Acta urologica Japonica (2024)
An 81-year-old man with prostate cancer (cT3aN0M0), who had been undergoing hormonal therapy for 4 years and had maintained low prostate specific antigen levels, developed metastasized pelvic lymph nodes. A tissue biopsy revealed neuroendocrine differentiation of prostate cancer in the metastatic lymph nodes. Consequently, chemotherapy with carboplatin+etoposide was initiated. During the first course, filgrastim was administered for 2 days due to a drop in his neutrophil count to 230/μl. During the second course, pegfilgrastim was administered as prophylaxis on day 4. However, on day 10 of the second course, he started to develop a fever and fatigue. Suspecting infection, antibiotics were administered, but failed to ameliorate his symptoms. On day 14, plain computed tomography revealed signs of aortic inflammation. Given the lack of improvement even after one week of antibiotic therapy, steroid treatment was initiated on the suspicion of granulocyte colony-stimulating factor (G-CSF) -induced aortitis, which rapidly improved his symptoms. Therefore, when encountering a case in which a fever remains unresponsive to antibiotics during chemotherapy with G-CSF agents, a differential diagnosis of aortic inflammation caused by G-CSF agents needs to be considered.
Keyphrases
- prostate cancer
- lymph node
- computed tomography
- radical prostatectomy
- oxidative stress
- aortic valve
- peripheral blood
- small cell lung cancer
- sleep quality
- squamous cell carcinoma
- left ventricular
- pulmonary artery
- locally advanced
- randomized controlled trial
- magnetic resonance imaging
- heart failure
- diabetic rats
- metabolic syndrome
- rectal cancer
- replacement therapy
- early stage
- atrial fibrillation
- neoadjuvant chemotherapy
- combination therapy
- insulin resistance
- endothelial cells
- dual energy
- recombinant human